Translational research funding boost
24 November 2017
A prestigious award from the National Health and Medical Research Council (NHMRC) has been presented to Associate Professor Rachael Morton, an Investigator at Melanoma Institute Australia and Research Theme Leader for Society, Policy and Economics.
The NHMRC Translating Research Into Practice (TRIP) Fellowship aims to support future leaders to undertake projects focused on translating evidence into practice that will have a deep impact on health care.
The funding will help researchers at Melanoma Institute Australia continue their ground-breaking research in melanoma that will change the way melanoma treatment is assessed in the future.
A/Prof Morton will use the funding to incorporate Patient Reported Outcome Measures (PROMs) into clinical quality registries.
“PROMs are an important method to better understand outcomes that matter to patients and include any metric assessing health, illness or health care benefits from the patient’s perspective, such as a questionnaire,” explains A/Prof Morton. “In the clinic, PROMs have the potential to highlight relevant symptoms and changes in symptoms, promote patient engagement in their treatment and improve patient outcomes.”
“Instruments measuring the patient’s perspective have been available for decades; however their incorporation into routine clinical practice has until recently been slow. We hope to facilitate this process.”
The work from this Fellowship will help integrate PROMs into the new Australian Clinical Outcomes Register for Melanoma, also known as the Big Data for Melanoma project, which has been made possible by collective fundraising efforts from the national Melanoma March campaign.
Melanoma Institute Australia (MIA) has launched a free e-learning portal to educate healthcare professionals about the latest advances in melanoma diagnosis and treatment.
When David lost his life last year, he was 33, with three daughters under six.
Clinical trials are just that – trials in a clinical setting to evaluate the effectiveness or otherwise of individual and combination treatments.
Melanoma Institute Australia scooped the award pool at the Annual Scientific Meeting of the International Academy of Pathology.
Melanoma patients across Australia will benefit from the release of updated clinical care guidelines.
An American study has discovered a link between early detection and marital status in melanoma diagnosis.
An international course on melanoma pathology in Paris, France co-directed by Professor Richard Scolyer took place over the weekend.
Professor Richard Scolyer highlights the difficulties of diagnosis following the Australian Story feature program on Emma Betts.
Cancer Australia releases 'stage at diagnosis' data for top five incidence cancers – including melanoma
For the first time in Australia, national data has been released on cancer stage at diagnosis. This data explores the top five incidence cancers – female breast cancer, colorectal, lung, prostate cancers and melanoma.
'Dear Emma' - a tribute to the life and times of a young woman determined to raise awareness about melanoma.
Carole Renouf, CEO for MIA thanks Toyota for helping fuel ongoing melanoma research.
Fraser Dykes tackled the Kokoda Trail on an eight day trek in memory of his friend Mark 'Bod' Boddison.
Harvard’s Clinical Professor Martin Mihm and MIA’s Conjoint Medical Director Professor Richard Scoyler delivered a series of lectures on melanoma pathology in Vancouver, British Colombia this week at the world’s biggest annual pathology meeting.
A round of applause for a well deserved win.
A message from our CEO, Carole Renouf
Piction, Brisbane, Bahturst and Port Macquarie march to end melanoma.
Australian researchers have greater clarity on the best course of treatment for patients with advanced melanoma which has spread to the brain.
Melanoma treatment has come a long way in recent times, and the role that nurses play caring for melanoma patients has changed dramatically too.